Individual patient data analysis to assess modifications to the RECIST criteria
- 1 January 2009
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 45 (2), 248-260
- https://doi.org/10.1016/j.ejca.2008.10.027
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)European Journal Of Cancer, 2009
- Recommendations for the assessment of progression in randomised cancer treatment trialsEuropean Journal Of Cancer, 2009
- Evaluation of lymph nodes with RECIST 1.1European Journal Of Cancer, 2009
- Lessons learned from independent central reviewEuropean Journal Of Cancer, 2008
- Optimising the design of phase II oncology trials: The importance of randomisationEuropean Journal Of Cancer, 2008
- Phase II to III Study Comparing Doxorubicin and Docetaxel With Fluorouracil, Doxorubicin, and Cyclophosphamide As First-Line Chemotherapy in Patients With Metastatic Breast Cancer: Results of a Dutch Community Setting Trial for the Clinical Trial Group of the Comprehensive Cancer CentreJournal of Clinical Oncology, 2005
- Phase III Study of Weekly High-Dose Infusional Fluorouracil Plus Folinic Acid With or Without Irinotecan in Patients With Metastatic Colorectal Cancer: European Organisation for Research and Treatment of Cancer Gastrointestinal Group Study 40986Journal of Clinical Oncology, 2005
- Bevacizumab in Combination With Fluorouracil and Leucovorin: An Active Regimen for First-Line Metastatic Colorectal CancerJournal of Clinical Oncology, 2005
- Interobserver and Intraobserver Variability in Measurement of Non–Small-Cell Carcinoma Lung Lesions: Implications for Assessment of Tumor ResponseJournal of Clinical Oncology, 2003
- New Guidelines to Evaluate the Response to Treatment in Solid TumorsJNCI Journal of the National Cancer Institute, 2000